The idea that a longer duration of untreated psychosis (DUP) leads to poorer outcomes has
contributed to extensive changes in mental health services worldwide and has attracted …

BackgroundRemission and recovery rates for people with first-episode psychosis (FEP)
remain uncertain. AimsTo assess pooled prevalence rates of remission and recovery in FEP …

Background Cannabis use is associated with increased risk of later psychotic disorder but
whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of …

Background Schizophrenia, bipolar disorder and depression are associated with
inflammation. However, it is unclear whether associations of immunological proteins/traits …

Treatments have been developed and tested to successfully reduce the symptoms and
disabilities of many mental illnesses. Unfortunately, people distressed by these illnesses …

Objective: The present guidelines address the pharmacotherapy of schizophrenia in adults
across different stages, phases, and symptom domains. Method: Guidelines were developed …

BackgroundDuration of untreated psychosis (DUP) is one of the few potentially modifiable
predictors of outcomes of schizophrenia. Long DUP as a predictor of poor short-term …

BackgroundThere is a growing concern about the mental health of children and young
people (CYP) in the UK, with increasing demand for counselling services, admissions for …

Schizophrenia is the eighth leading cause of disability worldwide in people aged 15–44
years. Before antidopaminergic antipsychotics were introduced in the 1950s, no effective …

Summary Background China and India jointly account for 38% of the world population, so
understanding the burden attributed to mental, neurological, and substance use disorders …